stockrowClover Health Investments, Corp.
CLOV Healthcare Healthcare Plans
Clover Health Investments, Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 40.3% from fiscal 2024.
- Revenue
- +52.9%
- EPS
- +350.0%
- Free cash flow
- +508.9%
Quarter to September 2026, against a year earlier
Follow CLOV
Alert me
Clover Health Investments, Corp. (CLOV) Return on equity
Clover Health Investments, Corp.'s return on equity over the twelve months to 30 September 2026 was 3.40%, up 29.7 percentage points from fiscal 2025 (−26.3%). Over the past ten years it has ranged from −75.8% (fiscal 2022) to 1,591.2% (fiscal 2021); the current reading is higher than 43% of that period. That is below the Healthcare Plans industry median of 13.6% and above the Healthcare sector median of −26.0%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | −26.3% | (12.62) |
| FY2024 | −13.7% | 52.63 |
| FY2023 | −66.3% | 9.44 |
| FY2022 | −75.8% | (1,666.97) |
| FY2021 | 1,591.2% | 1,546.71 |
| FY2020 | 44.5% | (73.40) |
| FY2019 | 117.9% | — |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| OSCR Oscar Health, Inc. compare | 52.6% |
| PGNY Progyny, Inc. compare | 18.7% |
| CI Cigna Group compare | 14.0% |
| ALHC Alignment Healthcare, Inc. compare | 13.2% |
| ELV Elevance Health, Inc. compare | 11.6% |
| CNC Centene Corporation compare | 6.74% |
| HUM Humana Inc. compare | 6.65% |
| CLOV Clover Health Investments, Corp. | 3.40% |
| MOH Molina Healthcare, Inc compare | −1.15% |
| Healthcare Plans industry median | 13.6% |
| Healthcare sector median | −26.0% |
| Market median | 1.01% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on CLOV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement